BNP Paribas Financial Markets’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $555K | Buy |
103,566
+56,006
| +118% | +$300K | ﹤0.01% | 2513 |
|
|
2025
Q1 | $254K | Buy |
47,560
+41,988
| +754% | +$224K | ﹤0.01% | 2763 |
|
|
2024
Q4 | $49.8K | Buy |
+5,572
| New | +$49.8K | ﹤0.01% | 3588 |
|
|
2022
Q4 | – | Sell |
-119
| Closed | -$1.08K | – | 3415 |
|
|
2022
Q3 | $1.08K | Buy |
+119
| New | +$1.08K | ﹤0.01% | 3704 |
|
|
2021
Q3 | – | Sell |
-145
| Closed | -$1.84K | – | 3406 |
|
|
2021
Q2 | $1.84K | Sell |
145
-301
| -67% | -$3.82K | ﹤0.01% | 3292 |
|
|
2021
Q1 | $7.74K | Sell |
446
-127
| -22% | -$2.2K | ﹤0.01% | 3270 |
|
|
2020
Q4 | $7.36K | Sell |
573
-97
| -14% | -$1.25K | ﹤0.01% | 3282 |
|
|
2020
Q3 | $24.9K | Buy |
670
+557
| +493% | +$20.7K | ﹤0.01% | 3130 |
|
|
2020
Q2 | $4.35K | Buy |
+113
| New | +$4.35K | ﹤0.01% | 3430 |
|
|
2016
Q1 | – | Sell |
-12
| Closed | -$5.79K | – | 2695 |
|
|
2015
Q4 | $5.79K | Sell |
12
-2
| -14% | -$965 | ﹤0.01% | 3448 |
|
|
2015
Q3 | $6.76K | Buy |
+14
| New | +$6.76K | ﹤0.01% | 3465 |
|